Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pou2f3
|
ENSMUSG00000032015.9 | POU domain, class 2, transcription factor 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_43210151_43210928 | Pou2f3 | 170 | 0.937604 | -0.62 | 1.3e-07 | Click! |
chr9_43179632_43179783 | Pou2f3 | 26048 | 0.139224 | -0.52 | 1.9e-05 | Click! |
chr9_43200036_43200430 | Pou2f3 | 5522 | 0.171876 | -0.35 | 5.7e-03 | Click! |
chr9_43150015_43150392 | Pou2f3 | 6999 | 0.184419 | -0.34 | 8.7e-03 | Click! |
chr9_43150402_43150674 | Pou2f3 | 7334 | 0.183094 | -0.25 | 5.0e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_81077232_81078427 | 20.51 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chr11_94045498_94046076 | 18.13 |
Spag9 |
sperm associated antigen 9 |
1422 |
0.4 |
chr12_52699823_52700029 | 16.15 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
543 |
0.8 |
chr13_105248515_105248922 | 15.90 |
Rnf180 |
ring finger protein 180 |
22321 |
0.21 |
chr8_109248831_109249717 | 15.61 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
592 |
0.83 |
chr13_109443973_109444887 | 15.16 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
2247 |
0.46 |
chr13_84905458_84906287 | 14.53 |
Gm4059 |
predicted gene 4059 |
68445 |
0.12 |
chr16_39985449_39985644 | 14.03 |
Lsamp |
limbic system-associated membrane protein |
951 |
0.68 |
chr6_101198088_101199306 | 13.95 |
Gm26911 |
predicted gene, 26911 |
39 |
0.89 |
chr4_22484307_22484937 | 13.57 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
3744 |
0.2 |
chr8_54957960_54958420 | 13.42 |
Gm45263 |
predicted gene 45263 |
1629 |
0.32 |
chr2_6883618_6884699 | 13.08 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr10_49784845_49785206 | 13.04 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
1616 |
0.33 |
chr6_86031081_86032013 | 12.70 |
Add2 |
adducin 2 (beta) |
2800 |
0.16 |
chr7_128690432_128691249 | 12.59 |
Gm16044 |
predicted gene 16044 |
1849 |
0.17 |
chr8_112570000_112570856 | 12.44 |
Cntnap4 |
contactin associated protein-like 4 |
373 |
0.76 |
chr8_112572299_112572848 | 12.22 |
Cntnap4 |
contactin associated protein-like 4 |
2518 |
0.32 |
chr4_9270926_9271667 | 11.90 |
Clvs1 |
clavesin 1 |
159 |
0.96 |
chr7_94042433_94043470 | 11.85 |
Gm32647 |
predicted gene, 32647 |
199 |
0.97 |
chr8_109245493_109246323 | 11.59 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
3958 |
0.33 |
chr15_76519928_76521866 | 11.44 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr14_77159311_77160431 | 11.37 |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
3091 |
0.31 |
chr8_109248088_109248728 | 11.31 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
1458 |
0.54 |
chr16_77420100_77420782 | 11.29 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
1379 |
0.28 |
chr4_110284419_110284817 | 10.96 |
Elavl4 |
ELAV like RNA binding protein 4 |
1998 |
0.47 |
chr7_51629095_51630495 | 10.90 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
315 |
0.88 |
chr6_96113911_96115198 | 10.85 |
Tafa1 |
TAFA chemokine like family member 1 |
95 |
0.98 |
chrX_152643367_152644550 | 10.76 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chr9_113813101_113813610 | 10.56 |
Clasp2 |
CLIP associating protein 2 |
755 |
0.71 |
chr11_76466993_76468433 | 10.52 |
Abr |
active BCR-related gene |
585 |
0.77 |
chr1_115686481_115687365 | 10.39 |
Cntnap5a |
contactin associated protein-like 5A |
2167 |
0.34 |
chr3_76075315_76075943 | 10.37 |
Fstl5 |
follistatin-like 5 |
46 |
0.98 |
chr3_73055286_73056050 | 10.24 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
1275 |
0.44 |
chr6_54564534_54565307 | 10.03 |
Scrn1 |
secernin 1 |
1569 |
0.36 |
chr3_34654574_34655689 | 10.02 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
905 |
0.42 |
chr13_83734808_83735118 | 9.94 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2397 |
0.18 |
chr4_24429901_24430719 | 9.91 |
Gm27243 |
predicted gene 27243 |
580 |
0.79 |
chr15_26310303_26310668 | 9.85 |
Marchf11 |
membrane associated ring-CH-type finger 11 |
1421 |
0.58 |
chr4_22480645_22481269 | 9.75 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
7409 |
0.17 |
chr13_34126566_34127191 | 9.72 |
Tubb2b |
tubulin, beta 2B class IIB |
3476 |
0.13 |
chr17_91085493_91086001 | 9.65 |
Gm47307 |
predicted gene, 47307 |
2659 |
0.21 |
chr13_83740463_83741042 | 9.65 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1889 |
0.2 |
chr13_44843445_44844028 | 9.57 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
2953 |
0.28 |
chrX_165325643_165325925 | 9.55 |
Glra2 |
glycine receptor, alpha 2 subunit |
1609 |
0.56 |
chr1_6734529_6735444 | 9.54 |
St18 |
suppression of tumorigenicity 18 |
116 |
0.98 |
chr9_117870768_117871285 | 9.41 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
1558 |
0.39 |
chr3_80800286_80803016 | 9.36 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
928 |
0.67 |
chr10_57784547_57786586 | 9.35 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr1_165934491_165935029 | 9.27 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
140 |
0.95 |
chr5_98182267_98183697 | 9.18 |
Prdm8 |
PR domain containing 8 |
2004 |
0.26 |
chr12_61525659_61526870 | 9.13 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
2316 |
0.3 |
chr1_66324307_66324676 | 9.08 |
Map2 |
microtubule-associated protein 2 |
2389 |
0.27 |
chr3_17792584_17792950 | 8.96 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1153 |
0.46 |
chr3_8509825_8511666 | 8.94 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr2_136713069_136714459 | 8.91 |
Snap25 |
synaptosomal-associated protein 25 |
286 |
0.92 |
chr7_45784257_45784949 | 8.82 |
Sult2b1 |
sulfotransferase family, cytosolic, 2B, member 1 |
66 |
0.88 |
chr5_131532921_131534054 | 8.82 |
Auts2 |
autism susceptibility candidate 2 |
910 |
0.58 |
chr10_90576163_90577493 | 8.78 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
13 |
0.99 |
chr9_52148115_52149635 | 8.73 |
Zc3h12c |
zinc finger CCCH type containing 12C |
19236 |
0.18 |
chr3_13946382_13947629 | 8.64 |
Ralyl |
RALY RNA binding protein-like |
594 |
0.84 |
chr18_69500231_69501482 | 8.62 |
Tcf4 |
transcription factor 4 |
20 |
0.99 |
chr5_90339159_90340201 | 8.58 |
Ankrd17 |
ankyrin repeat domain 17 |
63 |
0.98 |
chr10_92163758_92164191 | 8.58 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
692 |
0.72 |
chr9_112232067_112232798 | 8.53 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
69 |
0.97 |
chr3_34652462_34653573 | 8.47 |
Sox2 |
SRY (sex determining region Y)-box 2 |
2612 |
0.16 |
chr10_81229656_81230911 | 8.43 |
Atcay |
ataxia, cerebellar, Cayman type |
502 |
0.53 |
chr13_83727321_83728283 | 8.40 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
304 |
0.83 |
chr14_75965288_75966045 | 8.36 |
Gm25517 |
predicted gene, 25517 |
6953 |
0.18 |
chr15_44705107_44706053 | 8.34 |
Sybu |
syntabulin (syntaxin-interacting) |
42208 |
0.15 |
chr4_78209143_78209724 | 8.34 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
2306 |
0.29 |
chr11_32001099_32002296 | 8.33 |
Nsg2 |
neuron specific gene family member 2 |
1195 |
0.52 |
chr8_33747278_33748028 | 8.31 |
Smim18 |
small integral membrane protein 18 |
117 |
0.95 |
chr14_124675118_124677112 | 8.18 |
Fgf14 |
fibroblast growth factor 14 |
1012 |
0.63 |
chr10_109008310_109009456 | 8.17 |
Syt1 |
synaptotagmin I |
217 |
0.96 |
chr13_84063384_84064052 | 8.15 |
Gm17750 |
predicted gene, 17750 |
1054 |
0.58 |
chr13_83729448_83730058 | 8.00 |
Gm26803 |
predicted gene, 26803 |
171 |
0.91 |
chrX_110811626_110812334 | 7.99 |
Gm44593 |
predicted gene 44593 |
344 |
0.89 |
chr12_41483283_41485192 | 7.98 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
2194 |
0.36 |
chr2_97468266_97469202 | 7.96 |
Lrrc4c |
leucine rich repeat containing 4C |
645 |
0.83 |
chr10_33621658_33622333 | 7.95 |
Gm47911 |
predicted gene, 47911 |
286 |
0.85 |
chr16_67618113_67618498 | 7.94 |
Cadm2 |
cell adhesion molecule 2 |
2188 |
0.39 |
chr8_108537198_108537924 | 7.93 |
Gm39244 |
predicted gene, 39244 |
340 |
0.92 |
chr18_31446492_31447667 | 7.87 |
Syt4 |
synaptotagmin IV |
327 |
0.87 |
chr1_157242024_157242632 | 7.81 |
Rasal2 |
RAS protein activator like 2 |
2162 |
0.36 |
chr1_70725543_70726581 | 7.80 |
Vwc2l |
von Willebrand factor C domain-containing protein 2-like |
139 |
0.98 |
chrX_103185161_103185695 | 7.73 |
Nap1l2 |
nucleosome assembly protein 1-like 2 |
1212 |
0.36 |
chr17_90452047_90452824 | 7.65 |
Nrxn1 |
neurexin I |
2387 |
0.31 |
chr3_118430889_118431675 | 7.61 |
Gm26871 |
predicted gene, 26871 |
958 |
0.44 |
chr13_48264468_48265300 | 7.54 |
A330033J07Rik |
RIKEN cDNA A330033J07 gene |
2261 |
0.19 |
chr13_84064321_84064873 | 7.53 |
Gm17750 |
predicted gene, 17750 |
175 |
0.96 |
chr3_4799014_4799414 | 7.51 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
279 |
0.93 |
chr10_92164315_92164805 | 7.45 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
106 |
0.97 |
chr6_21217917_21219303 | 7.44 |
Kcnd2 |
potassium voltage-gated channel, Shal-related family, member 2 |
3107 |
0.33 |
chr11_57011668_57012922 | 7.40 |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
339 |
0.94 |
chr2_6881874_6882908 | 7.37 |
Gm13389 |
predicted gene 13389 |
1879 |
0.3 |
chr12_72234504_72235243 | 7.36 |
Rtn1 |
reticulon 1 |
866 |
0.66 |
chr8_114911140_114911535 | 7.34 |
Gm22556 |
predicted gene, 22556 |
141576 |
0.05 |
chr13_83735558_83735982 | 7.32 |
Gm33366 |
predicted gene, 33366 |
2765 |
0.16 |
chr12_49396038_49396340 | 7.31 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
5530 |
0.14 |
chr4_33926104_33927188 | 7.30 |
Cnr1 |
cannabinoid receptor 1 (brain) |
444 |
0.88 |
chr1_66323360_66324079 | 7.24 |
Map2 |
microtubule-associated protein 2 |
1617 |
0.37 |
chr10_117676507_117677148 | 7.22 |
Cpm |
carboxypeptidase M |
934 |
0.48 |
chrX_147552308_147552607 | 7.19 |
Lrch2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
1593 |
0.47 |
chrX_165326738_165328112 | 7.18 |
Glra2 |
glycine receptor, alpha 2 subunit |
32 |
0.99 |
chr16_77235848_77236417 | 7.17 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
185 |
0.96 |
chr13_83724319_83724624 | 7.16 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3090 |
0.17 |
chr4_36954554_36954875 | 7.15 |
Gm12371 |
predicted gene 12371 |
1748 |
0.39 |
chr1_153665136_153666782 | 7.13 |
Rgs8 |
regulator of G-protein signaling 8 |
250 |
0.89 |
chr12_27337801_27337952 | 7.12 |
Sox11 |
SRY (sex determining region Y)-box 11 |
4698 |
0.32 |
chr10_92159598_92160059 | 7.12 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
2933 |
0.28 |
chr8_47284401_47285223 | 7.09 |
Stox2 |
storkhead box 2 |
4550 |
0.27 |
chr11_41999400_42000640 | 7.08 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
336 |
0.92 |
chr15_18820164_18820708 | 7.02 |
Cdh10 |
cadherin 10 |
107 |
0.96 |
chr1_66322822_66322976 | 6.99 |
Map2 |
microtubule-associated protein 2 |
797 |
0.63 |
chr6_55680133_55680881 | 6.99 |
Neurod6 |
neurogenic differentiation 6 |
756 |
0.69 |
chr18_43686487_43688415 | 6.99 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr4_13752540_13753163 | 6.99 |
Runx1t1 |
RUNX1 translocation partner 1 |
1554 |
0.54 |
chr4_148391829_148392098 | 6.99 |
Gm13200 |
predicted gene 13200 |
32503 |
0.12 |
chr18_59062200_59063436 | 6.98 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
307 |
0.94 |
chr18_21422902_21423149 | 6.96 |
Gm22886 |
predicted gene, 22886 |
42094 |
0.15 |
chr14_64588312_64589438 | 6.92 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
341 |
0.81 |
chr12_3368833_3369546 | 6.90 |
Gm48511 |
predicted gene, 48511 |
760 |
0.54 |
chr10_29145199_29145467 | 6.86 |
Gm9996 |
predicted gene 9996 |
1139 |
0.36 |
chr15_22549492_22550147 | 6.80 |
Cdh18 |
cadherin 18 |
797 |
0.78 |
chrX_84078164_84078482 | 6.79 |
Dmd |
dystrophin, muscular dystrophy |
1674 |
0.47 |
chr10_57787071_57787893 | 6.75 |
Fabp7 |
fatty acid binding protein 7, brain |
2559 |
0.25 |
chr19_47016270_47016724 | 6.73 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
1344 |
0.28 |
chr4_102256022_102256825 | 6.73 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
1193 |
0.63 |
chr12_49387532_49388566 | 6.70 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
1603 |
0.26 |
chr16_77536736_77537070 | 6.69 |
Gm36963 |
predicted gene, 36963 |
2979 |
0.17 |
chr9_36832384_36834135 | 6.68 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
376 |
0.83 |
chr15_25754177_25754669 | 6.67 |
Myo10 |
myosin X |
1444 |
0.48 |
chrX_64273727_64274331 | 6.60 |
Slitrk4 |
SLIT and NTRK-like family, member 4 |
1793 |
0.49 |
chr10_119820571_119821220 | 6.59 |
Grip1 |
glutamate receptor interacting protein 1 |
1370 |
0.48 |
chr6_55678280_55679200 | 6.58 |
Neurod6 |
neurogenic differentiation 6 |
2523 |
0.32 |
chr2_22624675_22625045 | 6.57 |
Gad2 |
glutamic acid decarboxylase 2 |
1556 |
0.29 |
chr10_34299043_34301066 | 6.55 |
Tspyl4 |
TSPY-like 4 |
798 |
0.4 |
chr16_59604123_59604920 | 6.53 |
Crybg3 |
beta-gamma crystallin domain containing 3 |
3542 |
0.24 |
chr18_80982763_80983698 | 6.52 |
Sall3 |
spalt like transcription factor 3 |
3306 |
0.17 |
chr16_77422348_77423278 | 6.50 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
993 |
0.4 |
chr5_131531005_131531424 | 6.49 |
Auts2 |
autism susceptibility candidate 2 |
3183 |
0.25 |
chr4_102590727_102591712 | 6.48 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
1376 |
0.58 |
chr5_117415205_117415356 | 6.47 |
Ksr2 |
kinase suppressor of ras 2 |
1280 |
0.37 |
chr15_98986812_98986963 | 6.46 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
993 |
0.33 |
chr1_81079850_81080061 | 6.46 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
2372 |
0.43 |
chr1_184997307_184998530 | 6.45 |
Mark1 |
MAP/microtubule affinity regulating kinase 1 |
1557 |
0.41 |
chr7_128689234_128689975 | 6.44 |
Gm43580 |
predicted gene 43580 |
1069 |
0.26 |
chr8_48508743_48509680 | 6.43 |
Tenm3 |
teneurin transmembrane protein 3 |
46102 |
0.19 |
chr3_28264634_28265464 | 6.41 |
Tnik |
TRAF2 and NCK interacting kinase |
1406 |
0.45 |
chr6_28828230_28829085 | 6.39 |
Lrrc4 |
leucine rich repeat containing 4 |
1688 |
0.37 |
chr6_136171003_136171483 | 6.38 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
646 |
0.69 |
chr3_17791717_17791961 | 6.38 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1882 |
0.32 |
chr3_45384939_45386122 | 6.35 |
Pcdh10 |
protocadherin 10 |
2897 |
0.22 |
chr18_34249968_34250119 | 6.31 |
Apc |
APC, WNT signaling pathway regulator |
2345 |
0.29 |
chr3_13472022_13472431 | 6.30 |
Gm2464 |
predicted gene 2464 |
397 |
0.59 |
chr19_4758474_4759201 | 6.29 |
Rbm4b |
RNA binding motif protein 4B |
1932 |
0.18 |
chrX_23281963_23282663 | 6.26 |
Klhl13 |
kelch-like 13 |
2516 |
0.41 |
chr11_34315414_34316667 | 6.26 |
Insyn2b |
inhibitory synaptic factor family member 2B |
1218 |
0.45 |
chr5_15937662_15938665 | 6.26 |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
3252 |
0.2 |
chr1_143644977_143645827 | 6.25 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
2877 |
0.24 |
chr7_131968073_131968591 | 6.24 |
Gpr26 |
G protein-coupled receptor 26 |
1872 |
0.37 |
chr3_5225104_5225624 | 6.24 |
Zfhx4 |
zinc finger homeodomain 4 |
3859 |
0.22 |
chr17_93198991_93201483 | 6.23 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr9_34490617_34491220 | 6.23 |
Kirrel3 |
kirre like nephrin family adhesion molecule 3 |
1982 |
0.37 |
chr7_6414737_6415889 | 6.22 |
Smim17 |
small integral membrane protein 17 |
138 |
0.89 |
chr16_77596529_77597235 | 6.20 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
1980 |
0.16 |
chr3_4796861_4798079 | 6.20 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
88 |
0.98 |
chr8_94995811_94996872 | 6.20 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
680 |
0.57 |
chr14_55055435_55055869 | 6.19 |
Gm20687 |
predicted gene 20687 |
159 |
0.87 |
chr14_60380755_60381381 | 6.18 |
Amer2 |
APC membrane recruitment 2 |
2782 |
0.3 |
chr5_131534533_131535200 | 6.16 |
Auts2 |
autism susceptibility candidate 2 |
469 |
0.81 |
chr2_22626293_22626566 | 6.13 |
Gad2 |
glutamic acid decarboxylase 2 |
3125 |
0.18 |
chr6_13837266_13838183 | 6.13 |
Gpr85 |
G protein-coupled receptor 85 |
483 |
0.82 |
chr9_112231189_112232055 | 6.12 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
280 |
0.9 |
chr12_29536127_29536438 | 6.10 |
Myt1l |
myelin transcription factor 1-like |
1060 |
0.47 |
chr7_82871690_82872524 | 6.10 |
Mex3b |
mex3 RNA binding family member B |
4774 |
0.17 |
chr2_165878024_165878453 | 6.09 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
199 |
0.9 |
chr2_22629047_22629444 | 6.09 |
Gad2 |
glutamic acid decarboxylase 2 |
5941 |
0.14 |
chr14_76419153_76419898 | 6.07 |
Tsc22d1 |
TSC22 domain family, member 1 |
697 |
0.78 |
chr12_52009968_52010722 | 6.05 |
Dtd2 |
D-tyrosyl-tRNA deacylase 2 |
3844 |
0.19 |
chr10_49786982_49787307 | 6.05 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
1610 |
0.28 |
chr1_66323058_66323271 | 6.03 |
Map2 |
microtubule-associated protein 2 |
1062 |
0.51 |
chr3_5225663_5226074 | 6.02 |
Zfhx4 |
zinc finger homeodomain 4 |
4363 |
0.22 |
chr12_31711352_31711698 | 6.00 |
Gpr22 |
G protein-coupled receptor 22 |
2401 |
0.25 |
chr2_77701567_77703605 | 5.99 |
Zfp385b |
zinc finger protein 385B |
686 |
0.8 |
chr10_34301557_34301950 | 5.97 |
Tspyl4 |
TSPY-like 4 |
2497 |
0.16 |
chr3_63851016_63851674 | 5.96 |
Plch1 |
phospholipase C, eta 1 |
14 |
0.97 |
chr8_109250884_109251908 | 5.95 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
1530 |
0.52 |
chrX_105390628_105392456 | 5.95 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
212 |
0.93 |
chr16_77418973_77419718 | 5.92 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
2475 |
0.17 |
chr4_110285249_110285423 | 5.90 |
Elavl4 |
ELAV like RNA binding protein 4 |
1280 |
0.61 |
chr16_63860769_63861945 | 5.89 |
Epha3 |
Eph receptor A3 |
2056 |
0.46 |
chr7_79503895_79504046 | 5.83 |
Mir9-3 |
microRNA 9-3 |
1294 |
0.25 |
chr19_47015958_47016210 | 5.83 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
931 |
0.38 |
chr4_82496866_82497618 | 5.81 |
Nfib |
nuclear factor I/B |
2074 |
0.34 |
chr13_105249002_105249192 | 5.81 |
Rnf180 |
ring finger protein 180 |
21942 |
0.21 |
chr13_83737592_83739114 | 5.81 |
Gm33366 |
predicted gene, 33366 |
182 |
0.66 |
chr14_124190642_124190962 | 5.80 |
Fgf14 |
fibroblast growth factor 14 |
2100 |
0.46 |
chr8_112571267_112571599 | 5.79 |
Cntnap4 |
contactin associated protein-like 4 |
1378 |
0.43 |
chr1_194622071_194623282 | 5.78 |
Plxna2 |
plexin A2 |
2851 |
0.26 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.4 | 36.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
6.6 | 19.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
5.3 | 5.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
4.4 | 8.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
4.2 | 16.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
4.1 | 16.5 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
4.1 | 28.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
3.9 | 3.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.7 | 3.7 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
3.2 | 35.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
3.2 | 13.0 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
3.2 | 6.4 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
3.1 | 9.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.1 | 12.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
3.0 | 9.0 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
3.0 | 15.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
3.0 | 15.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
2.9 | 8.8 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
2.6 | 7.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
2.6 | 13.0 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
2.5 | 10.2 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.5 | 22.5 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
2.5 | 7.5 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
2.4 | 4.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.4 | 4.8 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.3 | 7.0 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
2.3 | 6.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.3 | 15.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.2 | 11.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
2.2 | 8.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.1 | 27.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
2.1 | 10.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
2.1 | 14.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
2.0 | 7.9 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
2.0 | 7.9 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.9 | 5.7 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.9 | 15.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.9 | 14.9 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.8 | 18.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.8 | 5.3 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.7 | 13.7 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.7 | 5.1 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
1.7 | 11.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.6 | 9.8 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.6 | 4.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.6 | 6.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.6 | 4.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.5 | 4.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.5 | 4.6 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.5 | 1.5 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
1.5 | 3.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.5 | 3.0 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.5 | 5.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.4 | 4.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.4 | 10.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.3 | 4.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.3 | 5.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.3 | 10.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.3 | 6.6 | GO:1900164 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
1.3 | 4.0 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.2 | 21.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.2 | 14.9 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.2 | 2.4 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
1.2 | 3.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.2 | 10.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.1 | 4.6 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.1 | 4.6 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
1.1 | 4.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.1 | 3.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.1 | 3.3 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.1 | 8.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
1.1 | 8.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.1 | 4.4 | GO:0030091 | protein repair(GO:0030091) |
1.1 | 5.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.1 | 28.1 | GO:0007616 | long-term memory(GO:0007616) |
1.1 | 5.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.1 | 1.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.1 | 10.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.0 | 11.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.0 | 3.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.0 | 3.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.0 | 2.0 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.0 | 6.0 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.0 | 5.9 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.0 | 4.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.0 | 1.9 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.9 | 57.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.9 | 2.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.9 | 2.7 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.9 | 8.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.9 | 2.6 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.9 | 1.8 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.9 | 6.1 | GO:0001964 | startle response(GO:0001964) |
0.9 | 2.6 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.9 | 1.7 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.8 | 1.7 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.8 | 0.8 | GO:1904395 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.8 | 5.0 | GO:0030432 | peristalsis(GO:0030432) |
0.8 | 2.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.8 | 2.5 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.8 | 4.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.8 | 1.6 | GO:0031296 | B cell costimulation(GO:0031296) |
0.8 | 1.6 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.8 | 1.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.8 | 0.8 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.8 | 2.4 | GO:0030070 | insulin processing(GO:0030070) |
0.8 | 5.5 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.8 | 24.0 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.8 | 3.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.8 | 2.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.8 | 3.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.8 | 4.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.7 | 3.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.7 | 3.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.7 | 2.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.7 | 3.6 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.7 | 5.0 | GO:0008038 | neuron recognition(GO:0008038) |
0.7 | 1.4 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.7 | 6.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.7 | 6.9 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.7 | 2.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.7 | 0.7 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.7 | 0.7 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.7 | 2.0 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.6 | 3.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.6 | 0.6 | GO:0051665 | membrane raft localization(GO:0051665) |
0.6 | 1.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.6 | 5.7 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.6 | 48.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 1.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.6 | 4.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.6 | 5.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.6 | 1.3 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.6 | 6.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.6 | 3.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.6 | 1.8 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.6 | 1.8 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.6 | 1.8 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.6 | 1.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.6 | 0.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 2.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.6 | 1.7 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.6 | 1.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.6 | 6.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 9.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 3.8 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.5 | 3.8 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.5 | 1.6 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.5 | 0.5 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.5 | 1.1 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.5 | 0.5 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.5 | 0.5 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.5 | 0.5 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.5 | 2.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.5 | 0.5 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.5 | 0.5 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.5 | 1.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.5 | 1.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.5 | 2.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.5 | 6.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.5 | 1.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.5 | 2.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 0.9 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.5 | 4.7 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.5 | 1.4 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.5 | 0.9 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.5 | 12.1 | GO:0021766 | hippocampus development(GO:0021766) |
0.5 | 2.3 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.5 | 0.9 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.5 | 1.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 1.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.5 | 2.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 4.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.4 | 1.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.4 | 13.3 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.4 | 2.7 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 2.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.4 | 0.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 3.0 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.4 | 1.3 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.4 | 1.7 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.4 | 0.4 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.4 | 1.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.4 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 35.2 | GO:0007612 | learning(GO:0007612) |
0.4 | 1.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.4 | 1.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.4 | 4.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.4 | 0.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.4 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 1.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 1.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 2.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.4 | 0.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.4 | 0.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 0.8 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.4 | 0.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.4 | 1.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.4 | 0.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.4 | 1.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 3.9 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.4 | 1.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.4 | 0.4 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.4 | 0.8 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.4 | 0.8 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.4 | 2.6 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.4 | 0.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.4 | 2.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 2.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 0.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.4 | 5.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.4 | 0.7 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 1.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 0.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) determination of liver left/right asymmetry(GO:0071910) |
0.4 | 0.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.3 | 1.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 0.7 | GO:1902896 | terminal web assembly(GO:1902896) |
0.3 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.3 | 0.7 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 0.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.3 | 1.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 0.7 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.3 | 1.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.3 | 0.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 1.0 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.3 | 0.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.3 | 1.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.3 | 1.3 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.3 | 2.3 | GO:0015791 | polyol transport(GO:0015791) |
0.3 | 1.0 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.3 | 0.3 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 0.7 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.3 | 1.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 1.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.3 | 1.0 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.3 | 1.3 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.3 | 1.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.3 | 25.1 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.3 | 13.1 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.3 | 8.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 2.4 | GO:0046847 | filopodium assembly(GO:0046847) |
0.3 | 0.9 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 0.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 0.9 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 2.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 0.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 6.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.3 | 2.0 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 1.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 0.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.3 | 1.4 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.3 | 0.8 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.3 | 1.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 0.6 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.3 | 1.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 0.6 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.3 | 0.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.3 | 0.8 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 0.8 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 1.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 0.8 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.3 | 1.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 0.5 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.3 | 4.0 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
0.3 | 5.8 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.3 | 0.8 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 0.8 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.3 | 0.5 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.3 | 1.6 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.3 | 0.3 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.3 | 0.5 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.3 | 0.5 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.3 | 0.5 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.3 | 2.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.3 | 3.0 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.3 | 3.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.3 | 0.3 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.3 | 0.8 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 2.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.7 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 1.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 1.2 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 0.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.2 | 0.2 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.2 | 8.0 | GO:0050905 | neuromuscular process(GO:0050905) |
0.2 | 0.2 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.2 | 0.2 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.2 | 0.9 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.2 | 0.7 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.2 | 0.7 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 0.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.2 | 14.5 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.2 | 0.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 0.9 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.2 | 0.4 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.2 | 3.1 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.2 | 1.1 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.2 | 0.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.2 | 1.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.6 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 1.5 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 2.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.2 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 0.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 0.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.2 | 1.2 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.2 | 1.6 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.2 | 1.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 0.6 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.2 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.8 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 0.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 3.1 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.4 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.2 | 7.5 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.2 | 0.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.2 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 1.3 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.2 | 0.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 0.7 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 2.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.7 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.2 | 0.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.2 | 0.2 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.2 | 0.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 3.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 1.0 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 1.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.5 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 1.5 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.2 | 0.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.2 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 0.5 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.2 | 0.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.2 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.2 | 2.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.2 | 5.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.2 | 0.5 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.2 | 0.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 2.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 0.8 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 0.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 0.3 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 0.1 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.1 | 4.5 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 1.0 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.4 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.1 | 3.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 1.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.7 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.1 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.1 | 0.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.3 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.1 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 1.1 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.1 | 0.5 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.5 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.5 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 1.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 1.3 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.1 | 3.6 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.5 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.1 | 0.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.6 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.3 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.1 | 0.4 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 3.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.1 | 0.4 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.6 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 1.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.1 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 | 0.2 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.7 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.1 | 0.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.9 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 6.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.5 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.5 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 1.6 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.1 | 1.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 1.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.3 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.2 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 5.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.2 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 12.9 | GO:0048812 | neuron projection morphogenesis(GO:0048812) |
0.1 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.1 | 0.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.5 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 2.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 2.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.1 | GO:0099622 | cardiac muscle cell membrane repolarization(GO:0099622) |
0.1 | 1.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.5 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 2.2 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 1.5 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 2.3 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.2 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 1.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.4 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.5 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 1.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.1 | GO:1901656 | glycoside transport(GO:1901656) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 4.0 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 0.6 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.1 | 0.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.5 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 0.5 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.5 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 4.8 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 0.3 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.1 | 0.9 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 2.7 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.1 | 1.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 1.3 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 3.9 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.5 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) |
0.1 | 2.2 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.4 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.3 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 1.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 0.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.8 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.3 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.4 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.1 | GO:2000118 | sodium-dependent phosphate transport(GO:0044341) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.1 | GO:0044333 | planar cell polarity pathway involved in axis elongation(GO:0003402) Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.1 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.9 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.1 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.4 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.1 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.9 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.1 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.1 | 0.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.3 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.2 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.1 | 0.3 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.1 | 0.1 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.2 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.2 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 2.8 | GO:0071804 | cellular potassium ion transport(GO:0071804) |
0.1 | 0.2 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.1 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 1.7 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.2 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.1 | 0.5 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 0.5 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.0 | 0.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 1.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.0 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.7 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.1 | GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
0.0 | 0.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.0 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.1 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.1 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.0 | 0.0 | GO:0032762 | mast cell cytokine production(GO:0032762) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.2 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.2 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.0 | 0.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.0 | 0.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.0 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.0 | 0.0 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.0 | 0.0 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.3 | GO:1903319 | positive regulation of protein maturation(GO:1903319) |
0.0 | 0.5 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.0 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 1.8 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.2 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.0 | 0.3 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.1 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.0 | 0.1 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.0 | 0.9 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.0 | 0.4 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.0 | 0.7 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.2 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.0 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.0 | 0.1 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.0 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.0 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.0 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.0 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.0 | 0.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.1 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.0 | 0.1 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.6 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.0 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.0 | 0.0 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0021533 | cell differentiation in hindbrain(GO:0021533) |
0.0 | 0.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.0 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.0 | GO:0072677 | eosinophil migration(GO:0072677) |
0.0 | 0.0 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.0 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.0 | 0.0 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.0 | 0.0 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.0 | 0.0 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.0 | 0.0 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 16.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
3.5 | 10.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.7 | 10.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.3 | 9.4 | GO:0044308 | axonal spine(GO:0044308) |
2.3 | 11.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
2.1 | 16.8 | GO:0043083 | synaptic cleft(GO:0043083) |
2.1 | 16.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.8 | 16.6 | GO:0005883 | neurofilament(GO:0005883) |
1.8 | 26.4 | GO:0031045 | dense core granule(GO:0031045) |
1.7 | 1.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.6 | 11.4 | GO:0032584 | growth cone membrane(GO:0032584) |
1.6 | 11.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.5 | 12.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.4 | 10.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.4 | 70.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.4 | 23.6 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.4 | 6.9 | GO:0097433 | dense body(GO:0097433) |
1.1 | 24.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.1 | 51.6 | GO:0043198 | dendritic shaft(GO:0043198) |
1.1 | 7.7 | GO:0030673 | axolemma(GO:0030673) |
1.1 | 7.7 | GO:0071437 | invadopodium(GO:0071437) |
1.1 | 15.0 | GO:0031527 | filopodium membrane(GO:0031527) |
1.1 | 3.2 | GO:1990696 | USH2 complex(GO:1990696) |
1.0 | 6.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.0 | 1.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.9 | 12.6 | GO:0071565 | nBAF complex(GO:0071565) |
0.9 | 20.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.9 | 27.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.9 | 0.9 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.9 | 14.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.8 | 8.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.8 | 114.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.8 | 0.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.7 | 13.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.7 | 6.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.7 | 6.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 5.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.6 | 1.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 3.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.6 | 3.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.6 | 1.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 5.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.5 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.5 | 3.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 4.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 2.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.5 | 5.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.5 | 0.9 | GO:0097441 | basilar dendrite(GO:0097441) |
0.5 | 13.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 1.3 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.4 | 2.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 1.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.4 | 1.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 18.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 4.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.4 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 3.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.4 | 27.2 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 0.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.3 | 2.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 4.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 1.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 1.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 2.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 16.8 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 1.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 1.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 7.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 41.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 0.3 | GO:0044298 | cell body membrane(GO:0044298) |
0.3 | 5.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 1.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 8.4 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 1.7 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.3 | 0.5 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 6.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 5.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.3 | 1.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 1.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.2 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 0.5 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.2 | 0.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 1.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 12.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 0.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 2.0 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 0.5 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 1.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 10.5 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 0.5 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 0.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 1.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 1.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.4 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 1.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.5 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 1.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.3 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.5 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 5.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 4.3 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 2.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 1.1 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 9.7 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.5 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.4 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 9.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 2.7 | GO:0045202 | synapse(GO:0045202) |
0.0 | 2.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.4 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 11.7 | GO:0097458 | neuron part(GO:0097458) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.5 | GO:0045095 | keratin filament(GO:0045095) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.5 | 22.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
5.1 | 15.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
4.9 | 19.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
3.2 | 28.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
3.1 | 18.5 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.4 | 12.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.3 | 6.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.2 | 4.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.2 | 8.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.2 | 15.2 | GO:0043495 | protein anchor(GO:0043495) |
2.2 | 6.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.9 | 3.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.8 | 14.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.8 | 12.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.5 | 10.8 | GO:0003680 | AT DNA binding(GO:0003680) |
1.5 | 11.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.4 | 5.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.3 | 5.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.3 | 15.8 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.3 | 7.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.3 | 5.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.2 | 7.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.2 | 3.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.2 | 20.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.2 | 3.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.2 | 23.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.1 | 6.7 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.1 | 3.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.1 | 4.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.1 | 2.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.0 | 4.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.0 | 8.2 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.0 | 4.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
1.0 | 2.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.0 | 4.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.9 | 24.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.9 | 4.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.9 | 2.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.9 | 3.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.8 | 6.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.8 | 2.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.8 | 16.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.8 | 3.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.7 | 19.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.7 | 3.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.7 | 1.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.7 | 7.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.7 | 2.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.7 | 3.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 4.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.7 | 4.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.7 | 11.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.7 | 2.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.6 | 1.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.6 | 6.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.6 | 0.6 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.6 | 1.8 | GO:0034812 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.6 | 1.8 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.6 | 2.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.6 | 12.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.6 | 9.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.6 | 2.4 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.6 | 1.7 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.6 | 9.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.6 | 1.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.5 | 1.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 14.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.5 | 4.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.5 | 4.8 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.5 | 1.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.5 | 1.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.5 | 1.6 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 5.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 2.0 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.5 | 8.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.5 | 12.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.5 | 1.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.5 | 7.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.5 | 2.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 2.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.5 | 4.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.5 | 0.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.5 | 2.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 4.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.5 | 1.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.5 | 13.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.4 | 1.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 1.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.4 | 2.2 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.4 | 2.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 0.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.4 | 1.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 10.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 7.2 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 1.5 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.4 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 2.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 6.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.4 | 1.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 4.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 1.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 2.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.3 | 0.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.3 | 1.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 2.0 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 1.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 3.7 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 1.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 1.4 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 2.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 2.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 0.7 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 7.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 3.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 0.6 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.3 | 4.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 0.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 8.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 1.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 4.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 2.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 3.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 0.6 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.3 | 2.0 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 1.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 4.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 9.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 4.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 3.3 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 4.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 10.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.3 | 2.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 19.6 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.3 | 3.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 1.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.3 | 1.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 1.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 2.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 1.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 3.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 7.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 0.5 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 5.7 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 1.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 2.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.7 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 1.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 1.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 2.6 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.2 | 1.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 2.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 5.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 4.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 1.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 0.7 | GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.2 | 0.7 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 0.9 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 1.7 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 1.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 1.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 1.5 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 4.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 1.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 1.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 1.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.8 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.2 | 1.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 2.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 0.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 1.3 | GO:0018660 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 0.9 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 1.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.9 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 11.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 5.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 2.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 2.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 4.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 0.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 1.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 3.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 1.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 1.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 1.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 1.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 2.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 2.4 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 1.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.7 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 3.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 2.9 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 1.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 2.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 3.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.7 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 1.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 6.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.5 | GO:0034916 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.6 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 12.9 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 0.3 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.1 | 0.5 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.5 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 2.5 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 2.5 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 0.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.1 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.1 | 0.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 2.9 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.3 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.1 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 1.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.1 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 1.0 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 1.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 1.0 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 2.5 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.1 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.2 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.3 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 1.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.3 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.1 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 1.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 8.1 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 4.1 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 5.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 5.8 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 1.3 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.1 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.0 | 0.4 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.6 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 1.1 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.0 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 12.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 1.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 2.2 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.1 | GO:0008227 | G-protein coupled amine receptor activity(GO:0008227) |
0.0 | 0.5 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 3.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.0 | GO:0016531 | copper chaperone activity(GO:0016531) superoxide dismutase copper chaperone activity(GO:0016532) |
0.0 | 0.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 23.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.7 | 24.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.7 | 16.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.5 | 17.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.5 | 21.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 31.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.4 | 20.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 10.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 4.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 6.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 6.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 4.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 7.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 8.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 5.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 1.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 1.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 1.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 2.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 3.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 5.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 5.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 2.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 2.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 5.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 2.8 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
2.2 | 33.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.9 | 44.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.9 | 18.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.9 | 37.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.6 | 33.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.1 | 21.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.0 | 11.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.0 | 1.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.0 | 7.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.9 | 7.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.8 | 6.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.7 | 13.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.7 | 7.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.7 | 6.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.6 | 8.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.6 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.6 | 19.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 7.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.5 | 3.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.5 | 1.4 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.4 | 9.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 3.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.4 | 17.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 4.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 4.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 4.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 1.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.3 | 3.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 4.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.3 | 3.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 0.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.3 | 2.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 4.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 3.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 5.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 2.1 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.2 | 3.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 0.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 0.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 2.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 8.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 2.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 2.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 7.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 3.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 0.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 6.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 20.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 2.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 4.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 1.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.7 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.6 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 1.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 0.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 2.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 3.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 4.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 1.7 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 0.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 2.0 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.3 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 0.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |